Contact us

Please wait...

At a glance

The Cryo-Save difference – providing families who believe in the future of regenerative medicine and tissue engineering access to current and future stem cell therapies.

null
Specialised cord blood processing through the Sepax II FAMCORD protocol using a BioSafe Sepax blood processing kit. The kit is a closed, single-use system which minimises the risk of contamination during processing. UNIQUE IN SA.
null
Testing cord tissue stem cells to determine viability by fluorescent staining. FIRST IN SA. When storing with Cryo-Save, you are assured that your samples have been properly tested and verified to be suitable for long term storage.
null
Peace of mind, with photographic evidence of viable tissue stem cells (if required for future expansion and therapy). FIRST IN SA.
null
Cryo-Save South Africa is owned by two publicly listed companies, providing unmatched financial security for your investment.
null
Cryo-Save was established in 2000 and is represented in over 30 countries on three continents and is the largest cord blood bank in Europe with over six laboratories in Geneva, Belgium, Netherlands, Portugal, South Africa and UAE. It is ranked the world’s 5th most influential cord blood bank by BioInformant.
null
Esperite, Cryo-Save’s holding company in Europe, registered a patent to use cord tissue stem cells that will enable new, and more accessible and affordable therapeutic approaches to treat a broad spectrum of inflammatory and autoimmune diseases including type-1 diabetes, arthritis and multiple sclerosis.
null
Cryo-Save sponsors a multi-centre clinical trial investigating new treatments for cerebral palsy by infusing two types of stem cells derived from umbilical cord blood and tissue processed by Cryo-Save.
null
Cryo-Save together with the University of Cologne pioneered validated methods for cord tissue collection, viability testing, cryopreservation, and isolation of mesenchymal stem cells from umbilical cord tissue.
null
Cryo-Save is a founding member of the International Tissue Engineering Research Association, an international forum of scientists and researchers specialised in stem cells and tissue repair. Together with other universities in Europe and the Fraunhofer Institute, Cryo-Save has been selected to conduct fundamental research in the field of cryopreservation techniques for stem cells in an EU funded Framework Program.

Stem cells are powerful and have the ability to create and regenerate the organs, blood, tissue and immune system that make up our bodies. They have the function of growth and healing throughout life.

They can potentially save your baby from 80+ diseases

Blood forming stem cells from cord blood have been used to treat or cure more than 80 blood related diseases — conditions like leukaemia, lymphoma and bone marrow failures. The list keeps growing as science advances, too. Clinical trials are now underway to use stem cell therapies to potentially treat autism, cerebral palsy, diabetes, spinal injuries and others.

In some cases, your baby’s blood forming stem cells can be used to help other relatives as well. There is a 25% chance of them being a perfect match for siblings. Biological parents will always be at least a half match. Additionally, with cord blood stem cells, it is not always necessary to have a perfect match for a transplant.

Your baby’s stem cells have life-saving abilities.

Shouldn’t you know more about umbilical cord stem cell storage?

Blood forming stem cell transplants have been performed for more than 50 YEARS

More than 1 MILLION blood forming stem cell transplants have been performed worldwide

More than 35,000 cord blood transplants have been performed worldwide

null

Stem cells are powerful.
They have the ability to create and regenerate our organs, blood, tissue, and immune system, and are responsible for growth and healing throughout our lives.

null
Stem cells collected from umbilical cord blood (in a painless procedure) are used to treat many blood disorders, including leukemia, lymphoma, and other blood cancers.
null
Your baby’s umbilical cord stem cells are a perfect match for your baby and have a strong probability of matching siblings, in case of a life-saving stem cell transplant. Additionally, with cord blood stem cells, it is not always necessary to have a perfect match for a transplant.
null
Cord tissue stem cells may be used for future regenerative therapies, e.g. tissue, muscle and cartilage repair. Trials are underway to potentially use stem cell therapies to treat autism, cerebral palsy, diabetes, spinal injuries and a growing list of others.

Cryo-Save South Africa is part of the Cryo-Save Group, Europe’s largest private cord blood and tissue stem cell bank. Through its six international laboratories in Geneva, Belgium, Germany, Dubai, India and South Africa, Cryo-Save globally stores more than 310 000 samples and is represented in over 30 countries on six continents.

Locally, it is also part of the private equity stable of Ecsponent Limited, a JSE-listed financial services group. Cryo-Save forms part of the specialised Ecsponent Biotech that invests in products and services that promote the adoption of personalised and regenerative medicine among South Africans to improve their quality of life.

As part of your birthing plan, contact us as early in your pregnancy as possible.

Cryo-Save Partnerships

null

Cryo-Save South Africa has partnered with MULTIPLY, MMI Holdings’ wellness and rewards programme to provide members of the programme with an exclusive service when storing their baby’s umbilical cord stem cells at birth. To find out more, please contact us directly on info@cryo-save.co.za.

null

Cryo-Save South Africa has partnered with CAMAF Medical Scheme to provide their members with an exclusive service when it comes to storing their baby’s umbilical cord stem cells at birth. To find out more, please contact us directly on info@cryo-save.co.za.

null

Founding member of The South African Tissue Bank Association (SATiBA). SATiBA is a not-for-profit organisation that aims to support all South African tissue banks in regulatory and legal matters, data collection, training, accreditation, quality assurance, communication and collaboration, and more. There is a need for the industry to take responsibility for its own future and development due to a lack of government support and funding, but this can only be achieved through cooperation and agreement between the various stakeholders.

null

The Parent’s Guide to Cord Blood started out as a website in 1998. It was intended as an informal public service project in memory of Shai, the daughter of the founder Dr Frances Verter. In 2007 a Board of Directors was recruited, and the Parent’s Guide to Cord Blood incorporated as a non-profit foundation. The primary mission of the Parent’s Guide to Cord Blood is to educate parents with accurate and balanced information about cord blood medical therapies and cord blood storage options.

Who we are and why we care

5TH MOST INFLUENTIAL CORD BANK IN THE WORLD AND EUROPEAN MARKET LEADER

Cryo-Save is ranked the 5th most influential cord bank in the world by BioInformant, the global leader in stem cell market research, and remains the undisputed European leader in the stem cells industry after 17 years of technological excellence.

Established in 2000, Cryo-Save is the most experienced, reliable and technologically advanced family Stem Cell Bank in Europe with six fully-owned storage facilities throughout the world. We are collecting samples from more than 30 countries and currently storing more than 330.000 samples of stem cells sourced from perinatal tissues.

Cryo-Save is led by a team of medical and scientific professionals, ensuring the highest quality of processes from collection through to storage. The dedicated medical professional presence in all countries we operate provides our clients and partners with direct expert communication and support.

 

GENEVA FLAGSHIP LABORATORY

Values of excellence, quality, performance and sustainability

The flagship laboratory is located in Geneva with a further five facilities in Belgium, the Netherlands, Portugal, South Africa and UAE, each carrying the Swiss values of high quality, high security and a long-term view.

Cryo-Save is the largest European family stem cell bank fully authorised for autologous and allogeneic transplants by a State Agency for therapeutic products and is fully accredited as a licensed Organ and Tissue Establishment.

Laboratory facilities within the Cryo-Save network are locally registered and acknowledged to support stem cell storage services across the 25 countries where Cryo-Save is currently active. In addition to the local licensing requirements, met by the six processing and storage facilities, Cryo-Save holds several accreditations and certifications – ISO 9001, EUGMP/PICs and AABB.

Cryo-Save laboratories have over 15 years’ experience in processing, cryopreservation and quality development. We strive to continue implementing process improvements across all facilities to ensure that the Cryo-Save name stands synonymous with quality.

 

PREPARING FOR THE FUTURE

Processing capacity was scaled up at the Geneva site during 2015 in preparation for consolidating most of the European laboratory activities at this single, state-of-the-art, high-tech laboratory.

The portfolio of quality accreditations was expanded and will continue to grow in the coming year as we anticipate future quality improvements demanded by the medical industry. Geneva has replaced Belgium as the flagship facility for Cryo-Save offering the latest in technological advancement as well as cost efficiencies inherent in such a large scale, automated, high-throughput facility.

 

TRANSLATIONAL RESEARCH AND REGENERATIVE MEDICINE

The Cell Factory produces highest quality stem cells and exosomes according to GLP/GMP guidelines, using proprietary technology for expansion of mesenchymal stem cells (MSC).

  • Building new procedures and services from R&D within Esperite group
  • Bringing most advanced regenerative medicine into a clinical setting
  • Constant optimisation of stem cell processes ensuring maximum yields, purity and low production costs
  • In-house scientific and medical expertise ensuring optimal development
  • Five international patents
  • Clinical trials on disorders affecting children from birth
  • Leading an international consortium of experts